220 related articles for article (PubMed ID: 37210099)
1. Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial.
Furr Stimming E; Claassen DO; Kayson E; Goldstein J; Mehanna R; Zhang H; Liang GS; Haubenberger D;
Lancet Neurol; 2023 Jun; 22(6):494-504. PubMed ID: 37210099
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 study.
Reilmann R; Anderson KE; Feigin A; Tabrizi SJ; Leavitt BR; Stout JC; Piccini P; Schubert R; Loupe P; Wickenberg A; Borowsky B; Rynkowski G; Volkinshtein R; Li T; Savola JM; Hayden M; Gordon MF;
Lancet Neurol; 2024 Mar; 23(3):243-255. PubMed ID: 38280392
[TBL] [Abstract][Full Text] [Related]
3. KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia.
Hauser RA; Factor SA; Marder SR; Knesevich MA; Ramirez PM; Jimenez R; Burke J; Liang GS; O'Brien CF
Am J Psychiatry; 2017 May; 174(5):476-484. PubMed ID: 28320223
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood Disorder.
Josiassen RC; Kane JM; Liang GS; Burke J; O'Brien CF
Psychopharmacol Bull; 2017 Aug; 47(3):61-68. PubMed ID: 28839341
[TBL] [Abstract][Full Text] [Related]
5. The Effects of Valbenazine in Participants with Tardive Dyskinesia: Results of the 1-Year KINECT 3 Extension Study.
Factor SA; Remington G; Comella CL; Correll CU; Burke J; Jimenez R; Liang GS; O'Brien CF
J Clin Psychiatry; 2017; 78(9):1344-1350. PubMed ID: 29141124
[TBL] [Abstract][Full Text] [Related]
6. Safety, tolerability, and efficacy of PBT2 in Huntington's disease: a phase 2, randomised, double-blind, placebo-controlled trial.
Huntington Study Group Reach2HD Investigators
Lancet Neurol; 2015 Jan; 14(1):39-47. PubMed ID: 25467848
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of valbenazine in Japanese patients with tardive dyskinesia: A multicenter, randomized, double-blind, placebo-controlled study (J-KINECT).
Horiguchi J; Watanabe K; Kondo K; Iwatake A; Sakamoto H; Susuta Y; Masui H; Watanabe Y
Psychiatry Clin Neurosci; 2022 Nov; 76(11):560-569. PubMed ID: 36114799
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study.
Reilmann R; McGarry A; Grachev ID; Savola JM; Borowsky B; Eyal E; Gross N; Langbehn D; Schubert R; Wickenberg AT; Papapetropoulos S; Hayden M; Squitieri F; Kieburtz K; Landwehrmeyer GB; ;
Lancet Neurol; 2019 Feb; 18(2):165-176. PubMed ID: 30563778
[TBL] [Abstract][Full Text] [Related]
9. Tetrabenazine: for chorea associated with Huntington's disease.
Scott LJ
CNS Drugs; 2011 Dec; 25(12):1073-85. PubMed ID: 22133328
[TBL] [Abstract][Full Text] [Related]
10. The effects of valbenazine on tardive dyskinesia in patients with a primary mood disorder.
McIntyre RS; Calabrese JR; Nierenberg AA; Farahmand K; Yonan C; Siegert S; Burke J
J Affect Disord; 2019 Mar; 246():217-223. PubMed ID: 30583148
[TBL] [Abstract][Full Text] [Related]
11. The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study.
Frank S; Testa C; Edmondson MC; Goldstein J; Kayson E; Leavitt BR; Oakes D; O'Neill C; Vaughan C; Whaley J; Gross N; Gordon MF; Savola JM;
CNS Drugs; 2022 Nov; 36(11):1207-1216. PubMed ID: 36242718
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular Profile of Valbenazine: Analysis of Pooled Data from Three Randomized, Double-Blind, Placebo-Controlled Trials.
Thai-Cuarto D; O'Brien CF; Jimenez R; Liang GS; Burke J
Drug Saf; 2018 Apr; 41(4):429-440. PubMed ID: 29218680
[TBL] [Abstract][Full Text] [Related]
13. Deutetrabenazine for tardive dyskinesia and chorea associated with Huntington's disease: a review of clinical trial data.
Claassen DO; Philbin M; Carroll B
Expert Opin Pharmacother; 2019 Dec; 20(18):2209-2221. PubMed ID: 31613641
[No Abstract] [Full Text] [Related]
14. Deutetrabenazine: A Review in Chorea Associated with Huntington's Disease.
Heo YA; Scott LJ
Drugs; 2017 Nov; 77(17):1857-1864. PubMed ID: 29080203
[TBL] [Abstract][Full Text] [Related]
15. Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial.
Huntington Study Group
Neurology; 2006 Feb; 66(3):366-72. PubMed ID: 16476934
[TBL] [Abstract][Full Text] [Related]
16. A proof-of-concept study with SOM3355 (bevantolol hydrochloride) for reducing chorea in Huntington's disease.
Gamez J; Calopa M; Muñoz E; Ferré A; Huertas O; McAllister K; Reig N; Scart-Grès C; Insa R; Kulisevsky J
Br J Clin Pharmacol; 2023 May; 89(5):1656-1664. PubMed ID: 36494329
[TBL] [Abstract][Full Text] [Related]
17. Clozapine versus placebo in Huntington's disease: a double blind randomised comparative study.
van Vugt JP; Siesling S; Vergeer M; van der Velde EA; Roos RA
J Neurol Neurosurg Psychiatry; 1997 Jul; 63(1):35-9. PubMed ID: 9221965
[TBL] [Abstract][Full Text] [Related]
18. Abnormal involuntary movement scale in tardive dyskinesia: Minimal clinically important difference.
Stacy M; Sajatovic M; Kane JM; Cutler AJ; Liang GS; O'Brien CF; Correll CU
Mov Disord; 2019 Aug; 34(8):1203-1209. PubMed ID: 31234240
[TBL] [Abstract][Full Text] [Related]
19. Tetrabenazine as anti-chorea therapy in Huntington disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators.
Frank S
BMC Neurol; 2009 Dec; 9():62. PubMed ID: 20021666
[TBL] [Abstract][Full Text] [Related]
20. Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial.
Anderson KE; Stamler D; Davis MD; Factor SA; Hauser RA; Isojärvi J; Jarskog LF; Jimenez-Shahed J; Kumar R; McEvoy JP; Ochudlo S; Ondo WG; Fernandez HH
Lancet Psychiatry; 2017 Aug; 4(8):595-604. PubMed ID: 28668671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
